Indeed, we have previously shown that sGsn−/− mice control MCA205 LA‐OVA tumours better than WT mice because of increased DNGR‐1(CLEC9A)‐dependent cDC1‐cross presentation of dead cell‐associated tumour antigens [3]. The gene discussed is CLEC9A; the disease is neoplasm.